Primary objectives:
* To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life.
Secondary objectives:
* To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
women aged ≥18 and ≤ 55
who underwent surgery for early stage breast cancer
taking endocrine therapy for at least 3 months
providing an informed consent and completing the study questionnaires.
withdrawal of the informed consent, at any time